We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Maintenance of a Stable Karyotype Depends on Action of a Long Noncoding RNA

By LabMedica International staff writers
Posted on 05 Jan 2016
Print article
Image: Model of the PUMILIO protein family member PUM1 (pumilio RNA binding family member 1) (Photo courtesy of Wikimedia Commons).
Image: Model of the PUMILIO protein family member PUM1 (pumilio RNA binding family member 1) (Photo courtesy of Wikimedia Commons).
A long noncoding RNA (lncRNA) regulates cellular genomic stability by sequestering the PUMILIO proteins, which would otherwise drive chromosomal instability by repressing mitotic, DNA repair, and DNA replication factors.

Long noncoding RNAs (lncRNAs) are non-protein coding transcripts longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs such as microRNAs (miRNAs), short interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. LncRNAs have been found to be involved in numerous biological roles including imprinting, epigenetic gene regulation, cell cycle and apoptosis, and metastasis and prognosis in solid tumors. Most lncRNAs are expressed only in a few cells rather than whole tissues, or they are expressed at very low levels, making them difficult to study.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) described the initial functional analysis of a poorly characterized human lncRNA (LINC00657) that was induced after DNA damage. The investigators called this class of RNA “noncoding RNA activated by DNA damage”, or NORAD.

They reported in the December 24, 2015, online edition of the journal Cell that NORAD was highly conserved and abundant, with expression levels of approximately 500–1,000 copies per cell. Unexpectedly, inactivation of NORAD was found to trigger the dramatic development of aneuploidy in previously karyotypically stable cell lines.

The investigators showed that NORAD maintained genomic stability by sequestering the PUMILIO proteins PUM1 and PUM2 (pumilio RNA binding family member 1 and pumilio RNA binding family member 2), which repressed the stability and translation of mRNAs to which they bound. In the absence of NORAD, PUMILIO proteins drove chromosomal instability by repressing mitotic, DNA repair, and DNA replication factors.

"In the absence of the NORAD RNA, the number of chromosomes in cells becomes highly abnormal," said senior author Dr. Joshua Mendell, professor of molecular biology at the University of Texas Southwestern Medical Center. "This is an entirely new function for a noncoding RNA and may have implications in cancer biology since genomic instability is a hallmark of tumor cells."

Related Links:
University of Texas Southwestern Medical Center


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.